Li L - Search Results

1

Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.

Li L, Sun J, Liu N, Yu R, Zhang J, Pang J, Ou Q, Yin Y, Cui J, Yao X, Zhao R, Shao Y, Yuan S, Yu J. Li L, et al. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):382-394. doi: 10.1016/j.ijrobp.2022.07.1835. Epub 2022 Sep 24. Int J Radiat Oncol Biol Phys. 2023. PMID: 36167753

2

Potential ¹⁸F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy.

Li L, Liu N, Zhang H, Tao R, Zhao S, Chen Z, Fu Z, Li W, Xu L, Liu Y, Yu J, Yuan S. Li L, et al. Among authors: li w. Front Oncol. 2022 Aug 26;12:848266. doi: 10.3389/fonc.2022.848266. eCollection 2022. Front Oncol. 2022. PMID: 36091179 Free PMC article.

3

miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.

Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, Li RF, Liu YG. Fan CG, et al. Among authors: li rf, li l. Oncol Rep. 2011 Nov;26(5):1281-6. doi: 10.3892/or.2011.1375. Epub 2011 Jul 1. Oncol Rep. 2011. PMID: 21725618

4

A standardized method for quantifying proliferation by Ki-67 and cyclin A immunohistochemistry in breast cancer.

Mu K, Li L, Yang Q, Yun H, Kharaziha P, Ye DW, Auer G, Lagercrantz SB, Zetterberg A. Mu K, et al. Among authors: li l. Ann Diagn Pathol. 2015 Aug;19(4):243-8. doi: 10.1016/j.anndiagpath.2015.05.002. Epub 2015 May 12. Ann Diagn Pathol. 2015. PMID: 26049669

5

Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma.

Lai CY, Pan B, Luo Y, Liang WB, Chen J, Ye DM, Guo JN, Li L, Su ZX. Lai CY, et al. Among authors: li l. Mol Biol Rep. 2014 Jun;41(6):3651-7. doi: 10.1007/s11033-014-3229-z. Epub 2014 Feb 16. Mol Biol Rep. 2014. PMID: 24532139

6

Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancer.

Zhang X, Wu X, Su P, Gao Y, Meng B, Sun Y, Li L, Zhou Z, Zhou G. Zhang X, et al. Among authors: li l. PLoS One. 2012;7(11):e48492. doi: 10.1371/journal.pone.0048492. Epub 2012 Nov 2. PLoS One. 2012. PMID: 23133636 Free PMC article.

7

Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells.

Wu X, Zhang X, Sun L, Zhang H, Li L, Wang X, Li W, Su P, Hu J, Gao P, Zhou G. Wu X, et al. Among authors: li w, li l. Cell Physiol Biochem. 2013;32(2):344-54. doi: 10.1159/000354442. Epub 2013 Aug 14. Cell Physiol Biochem. 2013. PMID: 23988382 Free article.

8

Prognostic significance of calcium-sensing receptor in breast cancer.

Li X, Li L, Moran MS, Jiang L, Kong X, Zhang H, Zhang X, Haffty BG, Yang Q. Li X, et al. Among authors: li l. Tumour Biol. 2014 Jun;35(6):5709-15. doi: 10.1007/s13277-014-1756-9. Epub 2014 Mar 1. Tumour Biol. 2014. PMID: 24584713

9

Detection of gene copy number alterations in DCIS and invasive breast cancer by QM-FISH.

Pan A, Zhou Y, Mu K, Liu Y, Sun F, Li P, Li L. Pan A, et al. Among authors: li l, li p. Am J Transl Res. 2016 Nov 15;8(11):4994-5004. eCollection 2016. Am J Transl Res. 2016. PMID: 27904700 Free PMC article.

10

Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer.

Wu X, Zhang X, Zhang H, Su P, Li W, Li L, Wang Y, Liu W, Gao P, Zhou G. Wu X, et al. Among authors: li w, li l. Cancer Sci. 2012 May;103(5):959-67. doi: 10.1111/j.1349-7006.2012.02245.x. Epub 2012 Apr 3. Cancer Sci. 2012. PMID: 22348324 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100,274 results

Search Page

Filters